Merck (NYSE: MRK)
Merck Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Merck Company Info
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.
News & Analysis
What's Wrong With Merck's Stock?
Is the healthcare stock an underrated buy right now?
Top Commercial Real Estate Stocks
Commercial real estate stocks offer opportunities to get involved with some of the most interesting businesses in the world.
Billionaires Are Loading Up on This Surging Dow Stock. Should You?
Merck stock has handily outperformed the Dow Jones Industrial Average in 2024, sparked by aggressive buying from billionaires like Citadel's Kenneth Griffin.
2 Magnificent Stocks to Buy With $500
These reliable healthcare companies look attractive no matter how you slice it.
These Are Billionaires’ Favorite Healthcare Stocks
The Motley Fool analyzed 16 billionaire-led hedge funds to get an idea of their healthcare sector investment strategies.
Better Growth Play: Merck or The Vanguard Growth Index Fund?
Merck's shares are trading in bargain territory. Are they a better growth play than this popular Vanguard fund?
Merck Paid $208 Million to Stop Its Drugs From Working. Here's Why That's Bullish.
Being able to stop a drug's unwanted effects could lead to a larger market share.
2 Monster Stocks to Buy Without Any Hesitation
Investors can sleep easy at night with these stocks in their portfolios.
Valuation
Podcast Episodes
The Top Healthcare Stocks of 2018: Can They Continue in 2019?
These healthcare stocks crushed the S&P 500's return last year, but that doesn't guarantee they'll be top performers in 2019.
News! News! News! Here's What's Happened in Healthcare Last Week
From a big-time patent settlement between Merck & Co. and Bristol-Myers Squibb, to Johnson & Johnson's earnings, to Aetna and Humana's $37 billion merger bust, we dive into the details behind last week's biggest healthcare stories.
Patent Palooza: One Patent Battle in Hep C, And Another Patent Brawl Brewing On Capitol Hill
Merck, Gilead Sciences, and Ionis get a verdict in their patent suit, and Congress calls for a patent review of Medivation's Xtandi.
Earnings Transcripts
Merck (MRK) Q2 2024 Earnings Call Transcript
MRK earnings call for the period ending June 30, 2024.
Merck (MRK) Q1 2024 Earnings Call Transcript
MRK earnings call for the period ending March 31, 2024.
Merck (MRK) Q4 2023 Earnings Call Transcript
MRK earnings call for the period ending December 31, 2023.
Merck (MRK) Q3 2023 Earnings Call Transcript
MRK earnings call for the period ending September 30, 2023.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.